Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A WRAP TECHNOLOGIES, INC. Filed by: Iroquois Capital Management, LLC

May 15, 2026 8:54 AM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Includes (i) 557,521 shares of Common Stock, (ii) 1,410,344 shares of Common Stock issuable upon conversion of 2,045 shares of the Company's Series A Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iii) 825,000 shares of Common Stock issuable upon conversion of 1237.5 shares of the Company's Series B Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iv) 3,643,966 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 4.99% Beneficial Ownership Blocker), and (v) 375,000 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 9.99% Beneficial Ownership Blocker). As more fully described in Item 4, the Preferred Shares (as defined in Item 4) and certain Warrants are subject to a 4.99% Beneficial Ownership Blocker and certain Warrants are subject to a 9.99% Beneficial Ownership Blocker, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon conversion and/or exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes (i) 1,357,393 shares of Common Stock, (ii) 1,610,344 shares of Common Stock issuable upon conversion of 2,335 shares of the Company's Series A Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iii) 1,233,333 shares of Common Stock issuable upon conversion of 1,850 shares of the Company's Series B Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iv) 4,854,540 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 4.99% Beneficial Ownership Blocker), and (v) 800,000 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 9.99% Beneficial Ownership Blocker). As more fully described in Item 4, the Preferred Shares (as defined in Item 4) and certain Warrants are subject to a 4.99% Beneficial Ownership Blocker and certain Warrants are subject to a 9.99% Beneficial Ownership Blocker, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (5), (6), (7), (8) and (9) show the number of shares of Common Stock issuable upon conversion and/or exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes (i) 557,521 shares of Common Stock, (ii) 1,410,344 shares of Common Stock issuable upon conversion of 2,045 shares of the Company's Series A Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iii) 825,000 shares of Common Stock issuable upon conversion of 1237.5 shares of the Company's Series B Convertible Preferred Stock (subject to a 4.99% Beneficial Ownership Blocker), (iv) 3,643,966 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 4.99% Beneficial Ownership Blocker), and (v) 375,000 shares of Common Stock issuable upon exercise of certain Warrants (subject to a 9.99% Beneficial Ownership Blocker). As more fully described in Item 4, the Preferred Shares (as defined in Item 4) and certain Warrants are subject to a 4.99% Beneficial Ownership Blocker and certain Warrants are subject to a 9.99% Beneficial Ownership Blocker, and the percentage set forth in row (11) gives effect to such Beneficial Ownership Blockers (as defined in Item 4). The shares reported in rows (6), (8) and (9) show the number of shares of Common Stock issuable upon conversion and/or exercise of such reported securities, giving effect to the Beneficial Ownership Blockers.


SCHEDULE 13G



Iroquois Capital Management, LLC
Signature:/s/ Richard Abbe
Name/Title:Richard Abbe
Date:05/14/2026
Richard Abbe
Signature:/s/ Richard Abbe
Name/Title:Richard Abbe
Date:05/14/2026
Kimberly Page
Signature:/s/ Kimberly Page
Name/Title:Kimberly Page
Date:05/14/2026

Categories

SEC Filings